Beta Drugs Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

The Latest Trading Price of Beta Drugs Ltd is ₹ 1389 as of 07 May 09:29 . The P/E Ratio of Beta Drugs Ltd changed from 9.8 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 35.82% over 5 yearsThe P/E Ratio of Shree Ganesh Remedies Ltd changed from 30.5 on March 2024 to 39.6 on March 2025 . This represents a CAGR of 13.95% over 2 years The Market Cap of Beta Drugs Ltd changed from ₹ 115.37 crore on March 2021 to ₹ 1923 crore on March 2025 . This represents a CAGR of 75.55% over 5 yearsThe Market Cap of Shree Ganesh Remedies Ltd changed from ₹ 801.21 crore on March 2024 to ₹ 913.01 crore on March 2025 . This represents a CAGR of 6.75% over 2 years The revenue of Beta Drugs Ltd for the Dec '25 is ₹ 89.58 crore as compare to the Sep '25 revenue of ₹ 106.37 crore. This represent the decline of -15.78% The revenue of Shree Ganesh Remedies Ltd for the Dec '25 is ₹ 21.76 crore as compare to the Sep '25 revenue of ₹ 31 crore. This represent the decline of -29.81% The ebitda of Beta Drugs Ltd for the Dec '25 is ₹ 19.3 crore as compare to the Sep '25 ebitda of ₹ 24.3 crore. This represent the decline of -20.58% The ebitda of Shree Ganesh Remedies Ltd for the Dec '25 is ₹ 7.39 crore as compare to the Sep '25 ebitda of ₹ 10.31 crore. This represent the decline of -28.32% The net profit of Beta Drugs Ltd changed from ₹ 8.95 crore to ₹ 8.52 crore over 7 quarters. This represents a CAGR of -2.77% The net profit of Shree Ganesh Remedies Ltd changed from ₹ 5.42 crore to ₹ 3.09 crore over 7 quarters. This represents a CAGR of -27.46% The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 17.97 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

FAQs for the comparison of Beta Drugs Ltd and Shree Ganesh Remedies Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Shree Ganesh Remedies Ltd?

Market cap of Beta Drugs Ltd is 1,370 Cr while Market cap of Shree Ganesh Remedies Ltd is 620 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Shree Ganesh Remedies Ltd?

The stock performance of Beta Drugs Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Shree Ganesh Remedies Ltd?

As of May 7, 2026, the Beta Drugs Ltd stock price is INR ₹1352.1. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹483.35.

How do dividend payouts of Beta Drugs Ltd and Shree Ganesh Remedies Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.